Derivation of patient-specific human pluripotent stem cells via somatic cell nuclear transfer (SCNT) has the potential for applications in a range of therapeutic contexts. However, successful SCNT with human cells has proved challenging to achieve, and thus far has only been reported with fetal or infant somatic cells. In this study, we describe the application of a recently developed methodology for the generation of human ESCs via SCNT using dermal fibroblasts from 35-and 75-year-old males. Our study therefore demonstrates the applicability of SCNT for adult human cells and supports further investigation of SCNT as a strategy for regenerative medicine.
SUMMARY
Derivation of patient-specific human pluripotent stem cells via somatic cell nuclear transfer (SCNT) has the potential for applications in a range of therapeutic contexts. However, successful SCNT with human cells has proved challenging to achieve, and thus far has only been reported with fetal or infant somatic cells. In this study, we describe the application of a recently developed methodology for the generation of human ESCs via SCNT using dermal fibroblasts from 35-and 75-year-old males. Our study therefore demonstrates the applicability of SCNT for adult human cells and supports further investigation of SCNT as a strategy for regenerative medicine.
SCNT is a potentially valuable tool for generating genetically matched stem cells for research and therapeutic purposes (Lanza et al., 1999) . Despite cloning success in numerous animal species (Cibelli et al., 1998; Onishi et al., 2000; Polejaeva et al., 2000; Wakayama et al., 1998 Wakayama et al., , 2013 Wilmut et al., 1997) , the derivation of hESC lines from cloned human embryos has proven elusive. Only one group has reported the creation of SCNThESCs, and their lines were generated using fetal and infant female somatic cells as nuclear donors (Tachibana et al., 2013) . The incidence of many diseases that could be treated with pluripotent cell derivatives increases with age, so applications based on autologous cells would most likely involve aged nuclear donors. However, human SCNT has not yet been achieved using aged donor nuclei. Here we show that using an approach based on the protocol outlined by Tachibana et al. (2013) , hESCs can be generated by SCNT using dermal fibroblasts (DFBs) from both a middle-aged 35-year-old male and an elderly, 75-year-old male, suggesting that age-associated changes are not necessarily an impediment to SCNT-based nuclear reprogramming of human cells.
SCNT and induced pluripotent stem cell (iPSC) reprogramming are both inefficient processes. The generation of patientspecific pluripotent stem cells through either method depends upon the completion of nuclear reprogramming, i.e., the ''reversal of the differentiation state of a mature cell to one that is characteristic of the undifferentiated embryonic state'' (Hochedlinger and Jaenisch, 2006) . This process likely includes global changes in DNA methylation patterns and histone modifications, which must be reset to enable early embryonic gene transcription (Blelloch et al., 2006) . For many cell types, reprogramming is more difficult for adult cells than for fetal/infant cells, presumably at least in part because their epigenetic landscape is further removed from the pluripotent state.
To examine the effect of nuclear donor age on SCNT, we initially used a traditional SCNT protocol (see Figure S1 and Supplemental Information available online) to reconstruct embryos from 49 MII stage oocytes obtained from three egg donors and one DFB cell line (DFB-1) from a 35-year-old healthy adult male. In these experiments, a total of three reconstructed eggs developed to an early blastocyst stage at day 5, and one of them developed further to a hatching blastocyst at day 6 (Table S1 ). Notably, all three blastocysts were derived from oocytes obtained from one particular donor (DOE-B). After removal of the zona pellucidae, the three blastocysts were plated onto mitotically inactivated mouse fibroblast cells on day 6. The two early stage blastocysts formed trophoblast-like colonies, which died out a few days later. However, the hatched blastocyst made an initial outgrowth resembling an ESC colony within 3 days and eventually resulted in a stable hESC line. This ESC line (CHA-NT1) expressed OCT-4, SSEA-4, TRA-1-60, and TRA-1-81 ( Figure S1Ca ) and could form teratomas ( Figure S1Cb ). However, cytogenetic testing and molecular genotyping revealed it had a tetraploid karyotype (91, XXXY,-6, t[2:6]) (Figure S1Cc) , indicating that we failed to fully enucleate the oocyte prior to transfer of the donor cell nucleus.
Aneuploidy has been observed in monkey SCNT experiments and may contribute to developmental arrest of cloned embryos (Simerly et al., 2003) . We therefore tested the karyotypes of several cloned eggs that arrested at the eight-cell stage as well as those of the two nonhatching blastocysts. Due to the limited amount of material, we used a molecular karyotyping method that involves whole-genome amplification from a single cell (Chung et al., 2009; Treff et al., 2010) . Interestingly, of the eight samples that generated a quantifiable amount of DNA, all of them had normal diploid karyotypes, and thus it did not seem that aneuploidy was the main cause of developmental arrest in these embryos (Table S2) . We also tested supplementation of half of the cloned embryos with mRNA for two centrosomal proteins that might have been depleted during enucleation (Simerly et al., 2003) (Figure S1Cd ), but this approach did not enhance cloning efficiency in our hands (Table S1 ).
As we were not able to generate diploid SCNT hESCs with our original protocol, we then moved to a different approach. Technical changes to an otherwise standard SCNT protocol helped Mitalipov and colleagues achieve generation of human SCNThESCs (Tachibana et al., 2013) using young (infant/fetal) donor cells. However the question remained of whether the same method would be effective with adult donor nuclei of different ages. In addition to differences in epigenetic signature relative to fetal or embryonic cells (Blelloch et al., 2006) , age-related changes such as shortened telomeres and oxidative DNA damage could hinder successful reprogramming of elderly adult donor nuclei. SCNT studies in cattle have examined the effects of somatic donor nucleus age on cloning efficiency (Tian et al., 2003) , but it remains unclear whether donor age impedes SCNT cloning success. To examine this issue for human SCNT, we used 77 MII stage oocytes collected from four egg donors using the same ovarian stimulation regimen as in the first set of experiments and two male donors, one aged 35 and one aged 75, as adult nuclear donors. Our procedures and culture media were similar to those described by Tachibana et al. (2013) , but about half of the reconstructed eggs were activated 2 hr instead of 30 min after fusion. By day 6, we obtained five total blastocysts: two expanded from the 30 min group and three expanded from the 2 hr group, but only those from the 2 hr group developed to become hatching blastocysts.
As in the first set of experiments, all of the cloned embryos that developed to blastocysts came from oocytes obtained from particular egg donors (DOE-D and DOE-G) ( Table 1 ). All five blastocysts were plated onto MEFs in hESC-derivation medium, but only the hatching blastocysts produced initial outgrowths and led to the generation of two karyotypically normal (46, XY) diploid ESC lines, one from the 75-year-old donor (CHA-NT2) and one from the 35-year-old donor (CHA-NT4) (Figure 1) .
Sixteen Short Tandem Repeat (STR) markers located at 15 human autosomal loci and 1 X/Y locus confirmed that the genotypes of both CHA-NT2 and CHA-NT4 hESC lines perfectly matched their respective nuclear donors but were different from their oocyte donors ( Figure 1C ). We also verified that the mitochondrial genomes of CHA-NT2 and CHA-NT4 matched those of oocyte donors ( Figure 1D ), confirming that the cytoplasm of our SCNT-hESC lines originated from the donor oocytes. CHA-NT2 and CHA-NT4 hESCs expressed OCT-4, SSEA-4, TRA-1-60, and TRA-1-81 ( Figure 1A ) and showed a growth rate similar to that of conventional IVF embryo-derived ESCs (CHA-hES-15, p55) (Lee et al., 2010) . We verified that the DFB cells did not contain any OCT-4-, SSEA-4-, TRA-1-60-, or TRA-1-81-positive cells (data not shown), supporting the finding that CHA-NT2 and CHA-NT4 hESCs were the result of reprogramming and not an artifact due to nuclear transfer from a contaminating multipotent cell. We confirmed spontaneous differentiation into all three germ layers in vitro by RT-PCR (Figure S2A ) and immunostaining of embryoid bodies ( Figure S2C) . Teratoma formation assays also demonstrated the outgrowth of tissue from all three germ layers ( Figure S2B ), further confirming the pluripotency of the CHA-NT2 line. We also tested the recovery of CHA-NT2 after a standard cryopreservation procedure and found that 60.6% (60/99) of colonies survived and regrew on MEFs. In addition, a normal karyotype was confirmed up to at least 30 passages (data not shown).
The slightly prolonged incubation time before activation that we applied may provide extra time for reprogramming before the start of embryonic gene transcription, which begins by the eight-cell stage for humans (Telford et al., 1990 ; Zhang et al., DFB-1: 35-year-old male; DFB-2: 75-year-old male. Incubation time prior to activation (30 min versus 2 hr) does not drastically alter cloning efficiency; however, the hatching blastocysts were obtained only from the 2 hr group. See also Table S1 and Table S2 . a Karyotyping showed normal 46 XY diploidy. b There were no significant differences between the two treatment groups at any developmental stage (X 2 -test, p > 0.05). 
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Human SCNT Using Adult Cells 2009) and thus may enhance developmental progression of cloned embryos. Similar results have been observed in animal studies (Aston et al., 2006; Liu et al., 2001; Wakayama et al., 1998) . We used both a 30 min and 2 hr incubation time with the 35-and 75-year-old donor nuclei and found no differences in terms of embryo development up to the blastocyst stage (p > 0.05, X 2 -test), but we only obtained hatching blastocysts and subsequent ESC lines from the 2 hr treatment group (Table 1) . As we saw in our earlier experiments, the embryos that developed the furthest were from the same oocyte donors even though the SCNT procedure was different. This finding suggests that genetic variation between egg donors may play an important role in the developmental potential of cloned embryos and is consistent with observations made by Tachibana et al. (2013) . Despite the success of SCNT in various animals, the generation of human ESC lines by SCNT has been notoriously difficult, with only one report demonstrating its use until now. The exact reason or reasons why the establishment of human ESC lines with SCNT is more difficult than it is for other species remains to be determined, although the results we report here suggest that aneuploidy is not a major factor. In this study, we confirm that modifications made to traditional SCNT procedures by Tachibana et al. (2013) allow the generation of hESCs using nuclear transfer, and we further show that refinement of this protocol allows the generation of SCNT hESCs using adult donors. Thus, despite epigenetic and other age-related changes that could hinder reprogramming, middle-aged and elderly adult donors can be used to generate pluripotent stem cells using nuclear transplantation. Our findings with regard to the effect of adjusting the postfusion interval also suggest that further optimization of SCNT protocols may allow this approach to be used more widely in regenerative medicine. 
